News

After Federal Funds Dry Up, Harvard and Other Universities Seek Lifeline From Tech Industry and Big Pharma for Research Grants ‘That has prompted immediate action out of sheer necessity,’ a top ...
Welcome to this week's Chutes & Ladders, our roundup | Incyte’s Hervé Hoppenot is hanging up his hat after spending more than a decade building the company into the multibillion-dollar ...
Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and NJ HQ expansion.
Sun Pharma has announced the appointment of Richard Ascroft as its new North America CEO, effective 16 June 2025. Based in Princeton, New Jersey, Ascroft will lead the pharmaceutical company’s ...
Press Releases MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS ...
Yi Sun-sin refused the suggestion, saying that people could easily assume there was some kind of favor or privilege being asked for or offered, and he wanted none of that kind of suspicion about him.
IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon Provided by ACCESS Newswire Jun 23, 2025, 5:30:00 AM ...
Review quarterly and annual revenue, net income, and cash flow for Sun Pharmaceuticals Industries Ltd (524715:XBOM) stock through the last fiscal year.
OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will be sent to local governments, people who became addicted to the ...
Press Releases MIRA Pharmaceuticals’ Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology ...
Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging ...